ALVIO.PA Stock - Valerio Therapeutics S.A.
Unlock GoAI Insights for ALVIO.PA
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $1.79M | $1.80M | $1.44M | $4.06M | $1.78M |
| Gross Profit | $1.28M | $1.27M | $929,000 | $3.69M | $1.43M |
| Gross Margin | 71.4% | 70.4% | 64.4% | 90.9% | 80.5% |
| Operating Income | $-16,489,000 | $-20,288,000 | $-17,115,000 | $-7,327,000 | $-8,938,000 |
| Net Income | $-23,931,000 | $-20,344,000 | $-19,562,000 | $-5,937,000 | $1.09M |
| Net Margin | -1334.7% | -1130.2% | -1355.6% | -146.2% | 61.3% |
| EPS | $-0.16 | $-0.15 | $-0.18 | $-0.07 | $0.01 |
Valerio Therapeutics Société anonyme, a clinical-stage biotechnology company, designs and develops oncology drugs for tumor DNA repair functions worldwide. The company offers Beleodaq for the treatment of peripheral T-cell lymphoma. It also develops AsiDNA, which is in Phase 1 clinical trial for the treatment of metastatic melanoma; OX401, which is in preclinical stage for treating DNA damage response and immuno-oncology; and platON, a decoy oligonucleotide platform. It has a license agreement with Acrotech Biopharma LLC; and clinical research agreement with Gustave Roussy to conduct clinical trial of AsiDNA for the treatment of relapsed ovarian cancer. The company was formerly known as Onxeo SA and changed its name to Valerio Therapeutics Société anonyme in June 2023. Valerio Therapeutics Société anonyme was incorporated in 1997 and is headquartered in Paris, France.
Visit WebsiteEarnings History & Surprises
ALVIO.PAEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q3 2025 | Aug 2, 2025 | — | — | — | — |
Q4 2024 | Oct 1, 2024 | — | $-0.07 | — | — |
Q2 2024 | May 1, 2024 | — | $-0.06 | — | — |
Q3 2023 | Jul 6, 2023 | — | $-0.10 | — | — |
Q2 2023 | Apr 25, 2023 | — | $-0.07 | — | — |
Q2 2022 | Jun 30, 2022 | — | $-0.11 | — | — |
Q4 2021 | Dec 31, 2021 | — | $-0.01 | — | — |
Q2 2021 | Jun 30, 2021 | — | $-0.06 | — | — |
Q4 2020 | Dec 31, 2020 | — | $-0.05 | — | — |
Q2 2020 | Jun 30, 2020 | — | $0.06 | — | — |
Q4 2019 | Dec 31, 2019 | — | $-0.41 | — | — |
Q2 2019 | Jun 30, 2019 | — | $-0.15 | — | — |
Q4 2018 | Dec 31, 2018 | — | $-0.01 | — | — |
Q2 2018 | Jun 30, 2018 | — | $-0.17 | — | — |
Q4 2017 | Dec 31, 2017 | — | $-0.94 | — | — |
Q2 2017 | Jun 30, 2017 | — | $-0.23 | — | — |
Q4 2016 | Dec 31, 2016 | — | $-0.22 | — | — |
Q2 2016 | Jun 30, 2016 | — | $-0.27 | — | — |
Q4 2015 | Dec 31, 2015 | — | $-0.20 | — | — |
Q2 2015 | Jun 30, 2015 | — | $-0.28 | — | — |
Latest News
Frequently Asked Questions about ALVIO.PA
What is ALVIO.PA's current stock price?
What is the analyst price target for ALVIO.PA?
What sector is Valerio Therapeutics S.A. in?
What is ALVIO.PA's market cap?
Does ALVIO.PA pay dividends?
Similar Stocks
Healthcare SectorExplore stocks similar to ALVIO.PA for comparison